News

University’s Welsh-language ambitions shared at Eisteddfod AmGen 2021

3 August 2021

Introduction to new Welsh Language Academy part of festival coverage

Success at Speaking of Science Conference

17 June 2021

A PhD student received recognition at an interdisciplinary conference for early career researchers, providing an engaging talk about research investigating prion disease through the medium of the Welsh language.

Award success for rare disease research

28 October 2020

Approximately 350 million people worldwide are living with a rare disease, and half of them are children. Vital research into lysosomal storage disorders has been recognised for its breakthrough discoveries and potential for impact for patients living with rare diseases.

Researchers working in a busy chemistry lab

Coleg Cymraeg Cenedlaethol PhD Opportunity

24 June 2020

Cardiff University’s Medicines Discovery Institute is offering a unique opportunity to research Amyotrophic Lateral Sclerosis through the medium of Welsh.

A year at the Medicines Discovery Institute

20 March 2020

A year since the Medicines Discovery Institute was launched, it’s team of researchers has secured millions in investment for new therapies in mental health and neuroscience.

Seedcorn funding for pancreatic cancer research

16 March 2020

There are over 10,000 new cases of pancreatic cancer diagnosed in the UK each year. New funding will enable the Medicines Discovery Institute to investigate potential new therapies for this deadly disease.

The Academy of Medical Sciences fund research into novel therapies

11 February 2020

The Academy of Medical Sciences is funding cutting-edge medicines discovery research for lysosomal storage disorders.

New insights for discovery of next generation antibiotics

5 September 2019

A new publication gives insight into interactions between antibiotics and Staphylococcus aureus DNA gyrase, helping to build a more detailed picture of how we can fight microbial resistance in the future.

ISSF award funds search for new Schizophrenia medication

2 September 2019

More than 23 million people are affected by schizophrenia, with people living with the condition being three times more likely to die early. New funding from the Wellcome Trust is supporting cutting-edge research that will improve therapies.

Gloves hand adjusting test tubes with yellow chemical

Wellcome Trust award funds NEAT1-related disease research

15 August 2019

The Institutional Strategic Support Fund by the Wellcome Trust has award over £48,000 to Cardiff University’s Medicines Discovery Institute to investigate a new target for a range of diseases.